NACE hay fever trial helps tackle springtime allergies

Published

Monday, October 6, 2025 - 12:00 PM

Allergic rhinitis, or hay fever, is Australia's most common allergy with more than 6.4 million cases reported in 2024, according to the new Deloitte Access Economics Report, Costly Reactions: The economic and social cost of allergic disease in Australia.

Unfortunately, most people do not seek medical care – and those that do use nasal sprays don’t use them properly.

Poor control of symptoms can lead to decreased physical and mental health and underperformance at school and work.

To help, the National Allergy Centre of Excellence (NACE), has just developed a hay fever trial, aiming to reduce hay fever symptoms for young Australians.

The online trial gives 14 to 29 year olds access to a specifically designed education package for participants to use, alongside their daily nasal spray. Recruitment is now open - register your interest.

If successful, the trial will change the way hay fever is managed in Australia, reducing the burden on those living with the disease, their families and the healthcare system.

In the media:

• Professor Connie Katelaris, ABC TV Breakfast
• Associate Professor Joy Lee, ABC Radio Ballarat
• Associate Professor Joy Lee and Michaela Diaz, NACE Consumer Advisory Group member, SBS Australia Explained